Sun BioPharma Culture | Comparably

Sun BioPharma Culture Company

Sun BioPharma Culture

Questo punteggio è derivato da dipendenti valutazioni e recensioni

Top Rated Cultura Dimensioni

N/A

CEO di Sun BioPharma

David Kaysen Sun BioPharma's CEO
David Kaysen

Informazioni sulla società

Indirizzo
105 CYPRESS LAGOON COURT
Ponte Vedra Beach, FL
United States of America
Sito web
sunbiopharma.com
Fondato
2011

descrizione dell'azienda

Sun BioPharma develops small molecule pharmaceuticals for the oncology and acute care markets.

Dirigenti con responsabilità strategiche

Nome e Titolo
Bio
David Kaysen  CEO / President
David Kaysen
CEO / President
David Kaysen serve come CEO / President di Sun BioPharma.
Jeffrey S. Mathiesen  Independent Director
Jeffrey S. Mathiesen
Independent Director
Mr. Jeffrey S. Mathiesen, also known as Jeff, CPA, has been Chief Financial Officer at Gemphire Therapeutics Inc., since September 2015 and serves as its Secretary. Mr. Mathiesen was a Consultant of Gemphire Therapeutics Inc. from August 2015 to September 2015. He has held executive positions with publicly traded companies dating back to 1993, including vice president and chief financial officer positions. Mr. Mathiesen served as the Chief Financial Officer and Company Secretary at CHF Solutions, Inc (Alternate name: Sunshine Heart Inc.) from March 2011 to January 2015 and from July 2011 to January 2015, respectively and also served as its Principal Accounting Officer until January 2015. He has more than 20 years of senior-level financial management experience with technology-based corporations. Prior to Sunshine Heart, he served as the Chief Financial Officer and Vice President of Zareba Systems, Inc. from December 9, 2005 to April 2010 and also served as its Principal Accounting Officer. He served as the Chief Financial Officer and Vice President of Delphax Technologies Inc. from July 2004 to December 9, 2005 and served as its Principal Accounting Officer. Mr. Mathiesen headed The Mathiesen Group Inc. from April 2003 to July 2004. From September 1996 to 2003, he served as Vice President and Chief Financial Officer and then Vice President of Business Development at Micro Component Technology Inc., St. Paul, Minn., supplier of automation equipment and software for the semiconductor industry. He served as a Vice President and Chief Financial Officer of Recovery Engineering Inc. from 1991 to 1996. Mr. Mathiesen began his business career with Deloitte & Touche LLP. He has been an Additional Director at Cimarron Medical, Inc. since September 24, 2015. He has been Director of NeuroOne Medical Technologies Corporation (Alternate name: NeuroOne, Inc.) since July 31, 2017. He has been Director of Sun BioPharma, Inc since September 30, 2015. He is a Certified Public Accountant. He is a summa cum laude graduate of the University of South Dakota, with a Bachelor of Science degree in Accounting.

Let Sun BioPharma sa che si desidera lavorare lì

Dici Sun BioPharma sei interessato a lavorare presso la società, pur mantenendo la vostra identità personale anonimo. Comparabilmente darà Sun BioPharma la possibilità di noleggiare you.When c'è un lavoro di apertura che è una misura faremo la partita accadere.

genere Score Come positivamente il giudizio delle donne la loro esperienza presso Sun BioPharma

N/A

diversità Score Come positivamente minoranze valutano la loro esperienza presso Sun BioPharma

N/A

Conosci qualcuno che lavora a Sun BioPharma?

Inviare loro un invito a valutare la cultura aziendale.

Anonimo Invia invito

×
Rate your company